Rein Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rein Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2024.
  • Rein Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $133K, a 50.7% decline year-over-year.
  • Rein Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $1.12M, a 6.13% decline year-over-year.
  • Rein Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1.12M, a 6.13% decline from 2023.
  • Rein Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.19M, a 42.9% decline from 2022.
  • Rein Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.08M, a 7.83% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.12M -$73K -6.13% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-07
2023 $1.19M -$893K -42.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-07
2022 $2.08M -$177K -7.83% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2021 $2.26M +$367K +19.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $1.89M -$223K -10.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $2.12M -$1.16M -35.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-24
2018 $3.28M +$1.53M +87.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $1.75M +$1.06M +154% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $688K +$62K +9.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $626K Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.